Sa1910 Long Term Outcomes of Crohn's Disease Patients on Maintenance Anti-TNF-α Therapy

Lilani P. Perera; Yelena Zadvornova; David G. Binion; Corinne Guilday; Dan Joseph Stein; Amar S. Naik; Nanda Venu; Kari Best; Susan Skaros

doi:10.1016/s0016-5085(12)61345-6

Related publications

Article2025

Long-term efficacy of therapeutic drug monitoring-guided optimization of ustekinumab maintenance therapy for Crohn’s disease patients

Haixia Ren, Juan Su, Anning Yin, Xinsheng Gao, Wei Wang, Jiao Li, Jian Jian Kang, Jing Wang, Qian Zhou, Jing An, Zhishun Tang, Xinxin Wang, Huipeng Wan, Wei‐Chung Chen, Pengbo Wu, Ping An

Article2009

Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease†

Dan Joseph Stein, Ashwin N. Ananthakrishnan, Mazen Issa, John B. Williams, Dawn B. Beaulieu, Yelena Zadvornova, Anita Ward, Kathryn Johnson, Josh F. Knox, Sue Skaros, David G. Binion

Article2012

Sa1229 Infliximab as Second Anti-TNF Agent in Crohn's Disease: Durability and Tolerance of Therapy

Jason E. Gonzaga, Yelena Zadvornova, Dan Joseph Stein, Lilani P. Perera, Amar S. Naik, Nanda Venu

Article2005

Guideline for anti-TNF-α therapy in psoriatic arthritis

Stuart Kyle, David Chandler, Christopher Em Griffiths, Philip Helliwell, James Lewis, Iain B. McInnes, S. Oliver, Deborah Symmons, Neil McHugh

Article2014

Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy

Raquel Franco Leal, Núria Planell, Radhika Kajekar, Juan José Lozano, Íngrid Ordás, Isabella Dotti, Manel Esteller, Maria Carme Masamunt, Harsukh Parmar, Elena Ricart, Julián Panés, Azucena Salas